Rhinovirus-induced VP1-specific Antibodies are Group-specific and Associated With Severity of Respiratory Symptoms.
Author(s)
Type
Journal Article
Abstract
BACKGROUND: Rhinoviruses (RVs) are a major cause of common colds and induce exacerbations of asthma and chronic inflammatory lung diseases. METHODS: We expressed and purified recombinant RV coat proteins VP1-4, non-structural proteins as well as N-terminal fragments of VP1 from four RV strains (RV14, 16, 89, C) covering the three known RV groups (RV-A, RV-B and RV-C) and measured specific IgG-subclass-, IgA- and IgM-responses by ELISA in subjects with different severities of asthma or without asthma before and after experimental infection with RV16. FINDINGS: Before infection subjects showed IgG1 > IgA > IgM > IgG3 cross-reactivity with N-terminal fragments from the representative VP1 proteins of the three RV groups. Antibody levels were higher in the asthmatic group as compared to the non-asthmatic subjects. Six weeks after infection with RV16, IgG1 antibodies showed a group-specific increase towards the N-terminal VP1 fragment, but not towards other capsid and non-structural proteins, which was highest in subjects with severe upper and lower respiratory symptoms. INTERPRETATION: Our results demonstrate that increases of antibodies towards the VP1 N-terminus are group-specific and associated with severity of respiratory symptoms and suggest that it may be possible to develop serological tests for identifying causative RV groups.
Date Issued
2014-11-18
Date Acceptance
2014-11-17
Citation
EBioMedicine, 2014, 2 (1), pp.64-70
ISSN
2352-3964
Publisher
Elsevier: Creative Commons
Start Page
64
End Page
70
Journal / Book Title
EBioMedicine
Volume
2
Issue
1
Copyright Statement
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
(http://creativecommons.org/licenses/by/3.0/).
License URL
Identifier
PII: S2352-3964(14)00036-X
Subjects
Antibody response
Asthma
COPD, Chronic obstructive pulmonary disease
ELISA, Enzyme-linked immunosorbent assay
HRP, Horseradish peroxidase
HSA, Human serum albumin
ICAM-1, Intercellular adhesion molecule 1
ICS, Inhaled corticosteroids
LDL-R, Low density lipoprotein receptor
MALDI–TOF, Matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry
MBP, Maltose binding protein
O.D, Optical density
PEF, Peak expiratory flow
RV, Rhinovirus
Recombinant rhinovirus coat protein
Rhinovirus
SABA, Short-acting β2 agonists
Serological test
TCID50, Tissue culture 50% infective dose
Publication Status
Published